Real-world evidence confirms clinical trial cutcomes for patients with SAPIEN 3 valve
Edwards Lifesciences announced 30-day data demonstrating treatment with Edwards SAPIEN 3 valve in more than 450 commercial centers around the U.S. show consistently positive patient outcomes. The data demonstrated consistency with those results achieved in earlier controlled clinical trials. May 22, 2018